Catalyst
Slingshot members are tracking this event:
Regeneron (REGN) and Sanofi's (SNY) Sarilumab for Rheumatoid Arthritis Granted PDUFA date of October 30, 2016 by FDA
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 28, 2016
Occurred Source:
http://files.shareholder.com/downloads/REGN/2696791652x0x914383/2087FE4E-4114-4AB7-B29E-939BAD979F4A/REGN_News_2016_10_28_General_Releases.pdf
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Sarilumab, Pdufa Date, Rheumatoid Arthritis, Sirukumab